NCT01703923View on ClinicalTrials.gov

An Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough

PHASE2CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Chronic Refractory Cough
Interventions
DRUG

FP01

DRUG

placebo

Trial Locations (8)

27612

Wake Research, LLC, Raleigh

28207

American Health Research, Charlotte

33186

South Florida Clinical Research Trials, LLC, Miami

33778

Sher Allergy Specialists, Largo

73131

Oklahoma Institute of Allergy and Asthma, Oklahoma City

74136

Allergy, Asthma and Immunology Center, P.C./ Vital Prospects Clinical Research Institute, P.C., Tulsa

95117

Allergy & Asthma Associates of Santa Clara Valley, San Jose

98225

Bellingham Asthma and Allergy Associates, Bellingham

Sponsors
All Listed Sponsors
lead

Avalo Therapeutics, Inc.

INDUSTRY

NCT01703923 - An Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough | Biotech Hunter | Biotech Hunter